These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Why should we care about quality of life in persons with haemophilia?
    Author: Aledort L, Bullinger M, von Mackensen S, Wasserman J, Young NL, Globe D, Health Related Quality of Life Expert Working Group of the International Prophylaxis Study Group.
    Journal: Haemophilia; 2012 May; 18(3):e154-7. PubMed ID: 22356125.
    Abstract:
    The very high cost of haemophilia care, including the increase in use of factor prophylaxis in both children and adults requires that funders of clotting factor concentrates require objective measures of health, such as joint status and quality of life (QOL). Many clinical trials, especially those for licensing of new products, are including QOL instruments in their protocols to evaluate the patients' perspective of wellbeing before and during therapy. This article gives a perspective on QOL the importance of QOL measurement in the field of haemophilia and its impact on patient outcome.
    [Abstract] [Full Text] [Related] [New Search]